Logo Image
|Articles|May 20, 2020

Advarra Calls Research Sites “Unsung Heroes” of COVID-19 Crisis

Advarra recognizes research sites as heroes of the COVID-19 crisis on Clinical Trials Day. On this day of celebration, Advarra wants to raise awareness of the unique circumstances that sites and institutions face during this crisis. To support research sites and institutions in their critical role in research, they are offering a free eLearning module that helps sites evaluate priorities and available resources to determine a plan for restarting studies. 

For more information, click here.

Related to this article

View more
The Human Side of Clinical Trials: How Measuring Readiness at Training Predicts Trial Risk Before It Shows Up in the Data
The Human Side of Clinical Trials: How Measuring Readiness at Training Predicts Trial Risk Before It Shows Up in the Data
This episode of The Human Side of Clinical Trials, hosted by Brian S. McGowan, PhD, FACEHP, chief learning officer and co-founder of ArcheMedX, Inc., and Kelly Ritch, chief operating officer of ArcheMedX, Inc., explores why training completion metrics like attendance and quiz scores fail to capture true study readiness, and how measuring both competence and confidence can reveal trial risks before enrollment even begins.
Read more
What the Epilepsy Community Has Taught Us About Trial Feasibility
What the Epilepsy Community Has Taught Us About Trial Feasibility
In this video interview, Amélie Lothe, global medical community head for rare epilepsies at UCB Pharma, shares what she has learned firsthand from families living with Dravet syndrome and CDKL5 deficiency disorder about what makes trial participation possible—and what makes it not.
Read more